Progyny, Inc. Shares Purchased by Barclays PLC
PGNY Stock | USD 14.34 0.15 1.06% |
Slightly above 60% of all Progyny's investors are looking to take a long position. The analysis of overall sentiment of trading Progyny stock suggests that some investors are interested at this time. Progyny's investing sentiment can be driven by a variety of factors including economic data, Progyny's earnings reports, geopolitical events, and overall market trends.
Progyny |
Barclays PLC grew its position in shares of Progyny, Inc. by 530.4 percent in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission . The fund owned 706,157 shares of the companys stock after acquiring an additional 594,140 shares during the quarter. Barclays PLC owned about
Read at thelincolnianonline.com
Progyny Investor Sentiment by Other News Outlets
Investor sentiment, mood or attitude towards Progyny can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Progyny Fundamental Analysis
We analyze Progyny's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Progyny using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Progyny based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Asset
Return On Asset Comparative Analysis
Progyny is currently under evaluation in return on asset category among its peers. Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.
Progyny Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Progyny stock to make a market-neutral strategy. Peer analysis of Progyny could also be used in its relative valuation, which is a method of valuing Progyny by comparing valuation metrics with similar companies.
Peers
Progyny Related Equities
PHR | Phreesia | 5.54 | ||||
TDOC | Teladoc | 5.24 | ||||
TXG | 10X Genomics | 3.16 | ||||
EVH | Evolent Health | 2.06 | ||||
VEEV | Veeva Systems | 2.04 | ||||
HCAT | Health Catalyst | 1.72 | ||||
CERT | Certara | 1.52 | ||||
DH | Definitive Healthcare | 0.97 | ||||
HSTM | HealthStream | 0.83 | ||||
NRC | National Research | 0.59 | ||||
PRVA | Privia Health | 0.30 | ||||
SLP | Simulations Plus | 1.04 | ||||
GDRX | Goodrx Holdings | 1.11 |
Additional Tools for Progyny Stock Analysis
When running Progyny's price analysis, check to measure Progyny's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Progyny is operating at the current time. Most of Progyny's value examination focuses on studying past and present price action to predict the probability of Progyny's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Progyny's price. Additionally, you may evaluate how the addition of Progyny to your portfolios can decrease your overall portfolio volatility.